MSB

MESOBLAST LIMITED

• ASX·4d ago

  High Survival Rates with Ryoncil in SR-aGvHD EIND Program

• The Motley Fool·4d ago

  Why this ASX healthcare share could double its value in 2026

• The Motley Fool·5d ago

  Here are the top 10 ASX 200 shares today

• ASX·02/08 21:14

  Becoming a substantial holder

• The Motley Fool·02/05 04:12

  5 ASX 200 shares forecast to soar 100% (or more) in 2026

• The Motley Fool·02/03 06:21

  These ASX 200 shares could rise 50% to 80%

• Dow Jones·01/29 22:55

  *Mesoblast Price Target Raised 11% to A$4.45/Share by Bell Potter

• The Motley Fool·01/29 21:48

  Could Mesoblast shares hit $4.45 in 2026?

• The Motley Fool·01/29 01:50

  This ASX 200 stock just reported a milestone quarter. So why are its shares falling?

• ASX·01/28 23:07

  Quarterly Activities/Appendix 4C Cash Flow Report

• ASX·01/26 23:21

  Real World Experience with Ryoncil Shows 84% Early Survival

• ASX·01/26 21:27

  Ceasing to be a substantial holder

• ASX·01/26 21:13

  Becoming a substantial holder

• The Motley Fool·01/22 19:15

  Has this ASX 200 stock just turned the corner after 7% surge?

• The Motley Fool·01/19 23:09

  This rising ASX 200 stock isn't done yet – or is it?